Installing biosafety level 3 containment laboratories in low- and middle-income countries: challenges and prospects from Mali's experience
In Mali, the incidence of tuberculosis (TB) is estimated at 56 cases per 100 000 people, with a prevalence of multidrug-resistant TB in new cases of 1.7% (range, 0.3–3.1%) and in retreatment cases of 17% (range, 4.4–30%). Appropriate biosafety conditions for performing routine TB culture and antimic...
Main Authors: | B. Kouriba, O. Ouwe Missi Oukem-Boyer, B. Traoré, A. Touré, L. Raskine, F.X. Babin |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2018-11-01
|
Series: | New Microbes and New Infections |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2052297518300465 |
Similar Items
-
G5 Sahel Biosafety Network: Successes and Challenges
by: Odile Ouwe Missi Oukem-Boyer, et al.
Published: (2020-05-01) -
Aerosol containment by airflow in biosafety laboratories
by: Xin Feng, et al.
Published: (2019-03-01) -
Performance of Mali's biosafety level 3 laboratory in the external quality assessment in preparedness of laboratory accreditation and support to clinical trials
by: N Coulibaly, et al.
Published: (2020-01-01) -
Are students kidding with health research ethics? The case of HIV/AIDS research in Cameroon
by: Munung Nchangwi, et al.
Published: (2012-06-01) -
Influenza Sentinel Surveillance among Patients with Influenza-Like-Illness and Severe Acute Respiratory Illness within the Framework of the National Reference Laboratory, Niger, 2009-2013.
by: Halima Boubacar Maïnassara, et al.
Published: (2015-01-01)